Grant
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
Parent SBIR grant opportunity funded by NIH, CDC, and FDA to support eligible US small businesses conducting R&D to develop commercial healthcare and biomedical products.
See your fitKey facts
- Organiser
- NIH, CDC and FDA (HHS)
- Deadline
- January 5, 2027
- Cycles
- January 2027 Submission · deadline January 5, 2027; April 2027 Submission · deadline April 5, 2027
- Opens
- August 5, 2026
- Amount
- Grant
- Open to
- United States
- Stages
- Pre-seed, Seed
- Sectors
- Biotech, Healthtech
4 details are locked
See your fit: whether you qualify, the official application form, and Autopilot to fill it in for you. Equity, fees, format and location open with it.
See your fitKey questions about NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
Who can apply to NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)?
NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) is aimed at startups at these stages: Pre-seed and Seed. Eligible locations: United States. The company must be incorporated in United States. Only startups in these sectors qualify: Biotech and Healthtech.
When is the NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) deadline?
The NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional) deadline is January 5, 2027. Upcoming cycles: January 2027 Submission · deadline January 5, 2027; April 2027 Submission · deadline April 5, 2027. Applications open on August 5, 2026.
Other programs in this category
- Alternative and Clean Energy Program (ACE)
- NIH, CDC and FDA Small Business Innovation Research Grant (Parent SBIR [R43/R44] Clinical Trial Optional)
- NLnet Foundation Open Calls (January 2027)
- Optimally Packaged Assembly for Laser Systems (OPALS)
- SBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
- Small Business Innovation Research and Small Business Technology Transfer Programs Phase II
Programs like this in the United States
Verified on November 4, 2026 against the official page.